Prof. Dr. Andreas Mackensen

Medical Degrees

• Studies in Human Medicine (Graduation) — Albert-Ludwigs-University of Freiburg, Germany, 1981–1988
• Medical-Technical Laboratory Assistant Training — Germany, 1981 (prior to medical studies)
• Doctorate (Dr. med.) — Germany
• Habilitation (Venia Legendi) — Germany
• Professor (Univ.-Prof.) of Internal Medicine — FAU Erlangen-Nürnberg

Fellowships & Special Training

• Specialist Certification (Facharzt) — Internal Medicine, Hematology & Medical Oncology
• Sub-specialty training in Stem-Cell Transplantation, CAR-T Cell Therapy and Cellular Immunotherapy
• Continuing professional development in immunotherapy, allogeneic SCT and clinical trial design

Certifications & Accreditations

• Bavarian State Medical Council — Registered Specialist in Internal Medicine, Hematology and Oncology
• Active President — Bavarian Cancer Research Center (BZKF)
• Speaker / Co-speaker of multiple DFG-funded research programmes (KFO146, TRR221)

Current Affiliation

• Director — Department of Medicine 5 (Hematology & Oncology), Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) (Present)
• Director — Transplant Center, Universitätsklinikum Erlangen (Present)
• Deputy Director — Comprehensive Cancer Center (CCC) Erlangen-EMN (Present)
• Active President & Founding Director — Bavarian Cancer Research Center (BZKF) (Present)
• Univ.-Prof. of Internal Medicine — FAU Erlangen-Nürnberg (Present)
• Speaker for Erlangen — DFG Collaborative Research Center (CRC) Transregio TRR221 (Present)

Past Affiliations

• Albert-Ludwigs-University of Freiburg — Medical Studies, 1981–1988
• Spokesman and Head — Clinical Research Group KFO146, DFG (Past)
• Co-speaker — Transregio SFB TRR221, DFG (Continuing)
• Member of Supervisory Board, Uniklinikum Erlangen (since 2012 – Present)

Academic & Research Roles

• Univ.-Prof. of Internal Medicine — FAU Erlangen-Nürnberg
• Founding Director, Bavarian Cancer Research Center (BZKF), 2019
• Spokesman and Head — Clinical Research Group KFO146 (DFG)
• Co-speaker — DFG Transregio SFB TRR221
• Erlangen is one of the few academic centres permitted to produce CAR-T cells in Europe (since 2019) — under his leadership
• Author of high-impact publications in Nature Medicine, The New England Journal of Medicine, Lancet and Blood

Key Achievements

• Pioneer of CAR-T cell therapy for severe autoimmune diseases (with Prof. Georg Schett — Erlangen CASTLE study, 2021)
• Vincenz Czerny Prize — German Society of Hematology and Oncology (DGHO), Vienna, 1994
• Young Investigator Award — International Association for Endotoxin Research, San Diego, 1990
• Active President & Founding Director, Bavarian Cancer Research Center (BZKF)
• Built the Erlangen CAR-T cell production and clinical programme — one of the few European academic CAR-T sites